NUVB compared with AARD: revenue, margins and what each company keeps, and the suppliers and customers both name

NUVBNuvation Bio Inc.

Mkt capRevenueRevenue

AARDAardvark Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

NUVBNuvation Bio Inc.

AARDAardvark Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

NUVBNuvation Bio Inc.

4.76▼−0.11%· post 4.76

Mkt cap$1.7BRevenue$32MQ2 FY26Revenue$63MFY25

AARDAardvark Therapeutics, Inc.

1.37▼−5.12%· post 1.35

ClosedOct 30 '26

Mkt cap$29.7MRevenue—Revenue—

Compare

ClosedOct 30 '26

NUVBNuvation Bio Inc.

AARDAardvark Therapeutics, Inc.

4.76▼−0.11%post 4.76

Price

1.37▼−5.12%post 1.35

$1.7B

Mkt cap

$29.7M

Q2 FY26$32M

Revenue

—

FY25$63M

Revenue

—

NUVB4.76▼−0.11%vsAARD1.37▼−5.12%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

NUVB, solidAARD, dashed

Supply-chain overlap

Revenue flow

NUVB: latest quarter is a loss; flow not drawable. AARD: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NUVB 4

—Daiichi Sankyounlistedsupplier

—Eisaiunlistedcustomer

—Innovent Biologics (Suzhou)unlistedcustomer

—Nippon Kayakuunlistedcustomer

Shared 0

No disclosed counterparties: AARD.

Only AARD 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR